These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

985 related articles for article (PubMed ID: 20729457)

  • 21. Percutaneous radiofrequency ablation of hepatocellular carcinoma: fusion imaging guidance for management of lesions with poor conspicuity at conventional sonography.
    Lee MW; Rhim H; Cha DI; Kim YJ; Choi D; Kim YS; Lim HK
    AJR Am J Roentgenol; 2012 Jun; 198(6):1438-44. PubMed ID: 22623560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical usefulness of the ablative margin assessed by magnetic resonance imaging with Gd-EOB-DTPA for radiofrequency ablation of hepatocellular carcinoma.
    Koda M; Tokunaga S; Okamoto T; Hodozuka M; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Sugihara T; Oyama K; Hosho K; Okano J; Murawaki Y; Kakite S; Yamashita E
    J Hepatol; 2015 Dec; 63(6):1360-7. PubMed ID: 26232269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging.
    Jiang C; Liu B; Chen S; Peng Z; Xie X; Kuang M
    Int J Hyperthermia; 2018 Dec; 34(8):1135-1141. PubMed ID: 29392978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real-time US-CT/MR fusion imaging for percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Ahn SJ; Lee JM; Lee DH; Lee SM; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK
    J Hepatol; 2017 Feb; 66(2):347-354. PubMed ID: 27650284
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth rate of new hepatocellular carcinoma after percutaneous radiofrequency ablation: evaluation with multiphase CT.
    Park Y; Choi D; Lim HK; Rhim H; Kim YS; Kim SH; Lee WJ
    AJR Am J Roentgenol; 2008 Jul; 191(1):215-20. PubMed ID: 18562748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Value of Nonrigid Registration of Pre-Procedure MR with Post-Procedure CT After Radiofrequency Ablation for Hepatocellular Carcinoma.
    Park J; Lee JM; Lee DH; Joo I; Yoon JH; Park JY; Klotz E
    Cardiovasc Intervent Radiol; 2017 Jun; 40(6):873-883. PubMed ID: 28091728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.
    Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A
    Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin.
    Nakazawa T; Kokubu S; Shibuya A; Ono K; Watanabe M; Hidaka H; Tsuchihashi T; Saigenji K
    AJR Am J Roentgenol; 2007 Feb; 188(2):480-8. PubMed ID: 17242258
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
    Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
    J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improvement of ablative margins by the intraoperative use of CEUS-CT/MR image fusion in hepatocellular carcinoma.
    Li K; Su ZZ; Xu EJ; Ju JX; Meng XC; Zheng RQ
    BMC Cancer; 2016 Apr; 16():277. PubMed ID: 27090513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of ablative margin by unenhanced magnetic resonance imaging after radiofrequency ablation for hepatocellular carcinoma.
    Koda M; Tokunaga S; Miyoshi K; Kishina M; Fujise Y; Kato J; Matono T; Okamoto K; Murawaki Y; Kakite S
    Eur J Radiol; 2012 Oct; 81(10):2730-6. PubMed ID: 22137612
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CT-monitored minimal ablative margin control in single-session microwave ablation of liver tumors: an effective strategy for local tumor control.
    Joo I; Morrow KW; Raman SS; McWilliams JP; Sayre JW; Lu DS
    Eur Radiol; 2022 Sep; 32(9):6327-6335. PubMed ID: 35389047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of ablative margin on local tumor progression and survival in patients with HCC ≤4 cm after laser ablation.
    Francica G; Petrolati A; Di Stasio E; Pacella S; Stasi R; Pacella CM
    Acta Radiol; 2012 May; 53(4):394-400. PubMed ID: 22393158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.
    Kim CK; Choi D; Lim HK; Kim SH; Lee WJ; Kim MJ; Lee JY; Jeon YH; Lee J; Lee SJ; Lim JH
    Eur J Radiol; 2005 Oct; 56(1):66-73. PubMed ID: 15913940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the ablation margin of hepatocellular carcinoma using CEUS-CT/MR image fusion in a phantom model and in patients.
    Li K; Su Z; Xu E; Huang Q; Zeng Q; Zheng R
    BMC Cancer; 2017 Jan; 17(1):61. PubMed ID: 28103837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Three-Dimensional Measurement of Hepatocellular Carcinoma Ablation Zones and Margins for Predicting Local Tumor Progression.
    Hocquelet A; Trillaud H; Frulio N; Papadopoulos P; Balageas P; Salut C; Meyer M; Blanc JF; Montaudon M; Denis de Senneville B
    J Vasc Interv Radiol; 2016 Jul; 27(7):1038-1045.e2. PubMed ID: 27156743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraoperative radiofrequency ablation with or without tumorectomy for hepatocellular carcinoma in locations difficult for a percutaneous approach.
    Kim HO; Kim SK; Son BH; Yoo CH; Hong HP; Cho YK; Kim BI
    Hepatobiliary Pancreat Dis Int; 2009 Dec; 8(6):591-6. PubMed ID: 20007075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiofrequency ablation for hepatocellular carcinoma measuring 2 cm or smaller: results and risk factors for local recurrence.
    Kono M; Inoue T; Kudo M; Chishina H; Arizumi T; Takita M; Kitai S; Yada N; Hagiwara S; Minami Y; Ueshima K; Nishida N; Murakami T
    Dig Dis; 2014; 32(6):670-7. PubMed ID: 25376283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
    Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
    J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.